‘Europe Has To Make Up Its Mind’ – Medicines For Europe’s Sieger On The Path Ahead
At an eventful time for the European generics and biosimilars industry, Medicines for Europe interim president and Polpharma CEO Markus Sieger talks about what the European healthcare sector needs and what the off-patent sector can deliver.